Authors:
OHIRA N
TAKASUGI K
YORIOKA N
ITO T
KUSHIHATA S
TAKEMASA A
Citation: N. Ohira et al., DOSE-ESCALATION INDUCES TOLERANCE TO SIDE-EFFECTS OF ERYTHROPOIETIN IN A PATIENT WITH DIALYSIS ANEMIA - CASE-REPORT, Journal of international medical research, 26(2), 1998, pp. 102-105
Citation: A. Takemasa et al., INVESTIGATION OF THE INFLUENZA-LIKE SYMPTOMS ASSOCIATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY, Journal of international medical research, 25(3), 1997, pp. 127-134
Citation: A. Takemasa et al., STIMULATION OF INTERLEUKIN-1-BETA PRODUCTION MAY BE INVOLVED IN UNRESPONSIVENESS TO ERYTHROPOIETIN THERAPY, International journal of artificial organs, 19(11), 1996, pp. 633-637
Authors:
YORIOKA N
ODA H
OGAWA T
TANIGUCHI Y
KUSHIHATA S
TAKEMASA A
USUI K
SHIGEMOTO K
HARADA S
YAMAKIDO M
Citation: N. Yorioka et al., CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS IS SUPERIOR TO HEMODIALYSISIN CHRONIC DIALYSIS PATIENTS WITH CEREBRAL-HEMORRHAGE, Nephron, 67(3), 1994, pp. 365-366
Authors:
TAKEMASA A
YORIOKA N
ITO T
YAMASHITA K
ODA H
YAMAKIDO M
Citation: A. Takemasa et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN INCREASES INTERLEUKIN-1-BETA PRODUCTION IN CULTURED PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS RESISTANT TO RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY, Nephron, 67(2), 1994, pp. 245-247